SK
Therapeutic Areas
Celularity Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Placental-derived biomaterial products | Wound care / Tissue regeneration | Approved/Commercial |
| MLASC-based therapies | Degenerative Diseases | Phase 1/2 |
| NK Cell therapies | Oncology | Phase 1/2 |
| T Cell therapies | Immunology/Oncology | Phase 1/2 |
Leadership Team at Celularity
RJ
Robert J. Hariri
Chairperson, Founder, and Chief Executive Officer
SB
Stephen Brigido
President, Degenerative Diseases
JH
John Haines
Global Manager and Chief Administrative Officer
AG
Anna Gosiewska
R&D, Degenerative Diseases
CP
Carmine Palummo
Corporate Operations
TW
Tim Wilk
Technical Operations
PD
Peter Diamandis
Director
GS
Geoffrey Shiu Fei Ling
Director
DP
Diane Parks
Director
VL
Vincent LeVien
Director